Cargando…
Clinical evaluations of pituitary apoplexy in incidental nonfunctional pituitary adenomas
Pituitary apoplexy is an uncommon syndrome that often results in spontaneous hemorrhage or infarction of pituitary tumors or glands. We previously reported pituitary apoplexy occurred most frequently in nonfunctional pituitary adenomas among all types of pituitary incidentalomas. In the present stud...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9771219/ https://www.ncbi.nlm.nih.gov/pubmed/36550872 http://dx.doi.org/10.1097/MD.0000000000032026 |
_version_ | 1784854774098690048 |
---|---|
author | Takeshita, Kaori Abe, Ichiro Kameda, Wataru Ishii, Kota Fujita, Yuya Nagata, Mai Ochi, Kentaro Senda, Yuki Koga, Midori Kudo, Tadachika Hada, Yurika Takase, Kaoru Morinaga, Yusuke Ito, Miiko Abe, Makiko Ishizawa, Kenichi Kobayashi, Kunihisa |
author_facet | Takeshita, Kaori Abe, Ichiro Kameda, Wataru Ishii, Kota Fujita, Yuya Nagata, Mai Ochi, Kentaro Senda, Yuki Koga, Midori Kudo, Tadachika Hada, Yurika Takase, Kaoru Morinaga, Yusuke Ito, Miiko Abe, Makiko Ishizawa, Kenichi Kobayashi, Kunihisa |
author_sort | Takeshita, Kaori |
collection | PubMed |
description | Pituitary apoplexy is an uncommon syndrome that often results in spontaneous hemorrhage or infarction of pituitary tumors or glands. We previously reported pituitary apoplexy occurred most frequently in nonfunctional pituitary adenomas among all types of pituitary incidentalomas. In the present study, we aimed to investigate the characteristics of pituitary apoplexy in patients with incidental nonfunctional pituitary adenomas. 65 patients with pituitary incidentaloma were enrolled. All patients underwent clinical/endocrinological/pathological investigations. As a result, 33 patients were diagnosed with nonfunctional pituitary adenomas. Of these, 12.1% of patients had pituitary apoplexy. There was no difference in tumor diameter, age, or sex between the apoplexy and the non-apoplexy groups. However, the liver enzymes aspartate transaminase and alanine aminotransferase were significantly higher, and plasma sodium and chloride levels were significantly lower in the apoplexy group than in the non-apoplexy group (each P < .05). In addition, low-density lipoprotein-cholesterol was significantly higher in the apoplexy group than in the non-apoplexy group (P < .05). Besides, thyroid-stimulating hormone, luteinizing hormone, follicle-stimulating hormone, and prolactin deficiencies were significantly more frequent in the apoplexy group than in the non-apoplexy group (each P < .05), and growth hormone and adrenocorticotropic hormone deficiencies were more frequent in the apoplexy group than in the non-apoplexy group (P = .09 and.08, respectively). Furthermore, tumor diameter was not associated with pituitary apoplexy, whereas thyroid-stimulating hormone, luteinizing hormone, and follicle-stimulating hormone deficiencies were significantly associated with the apoplexy group (each P < .05). Hence, the present study indicated that pituitary apoplexy could not be related to tumor diameter. Moreover, hormonal deficiencies, hepatic dysfunction, hyponatremia or hypochloremia, and dyslipidemia might be indicators of pituitary apoplexy. There could be the possibility the treatment for dyslipidemia prevents pituitary apoplexy. |
format | Online Article Text |
id | pubmed-9771219 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-97712192022-12-22 Clinical evaluations of pituitary apoplexy in incidental nonfunctional pituitary adenomas Takeshita, Kaori Abe, Ichiro Kameda, Wataru Ishii, Kota Fujita, Yuya Nagata, Mai Ochi, Kentaro Senda, Yuki Koga, Midori Kudo, Tadachika Hada, Yurika Takase, Kaoru Morinaga, Yusuke Ito, Miiko Abe, Makiko Ishizawa, Kenichi Kobayashi, Kunihisa Medicine (Baltimore) 4300 Pituitary apoplexy is an uncommon syndrome that often results in spontaneous hemorrhage or infarction of pituitary tumors or glands. We previously reported pituitary apoplexy occurred most frequently in nonfunctional pituitary adenomas among all types of pituitary incidentalomas. In the present study, we aimed to investigate the characteristics of pituitary apoplexy in patients with incidental nonfunctional pituitary adenomas. 65 patients with pituitary incidentaloma were enrolled. All patients underwent clinical/endocrinological/pathological investigations. As a result, 33 patients were diagnosed with nonfunctional pituitary adenomas. Of these, 12.1% of patients had pituitary apoplexy. There was no difference in tumor diameter, age, or sex between the apoplexy and the non-apoplexy groups. However, the liver enzymes aspartate transaminase and alanine aminotransferase were significantly higher, and plasma sodium and chloride levels were significantly lower in the apoplexy group than in the non-apoplexy group (each P < .05). In addition, low-density lipoprotein-cholesterol was significantly higher in the apoplexy group than in the non-apoplexy group (P < .05). Besides, thyroid-stimulating hormone, luteinizing hormone, follicle-stimulating hormone, and prolactin deficiencies were significantly more frequent in the apoplexy group than in the non-apoplexy group (each P < .05), and growth hormone and adrenocorticotropic hormone deficiencies were more frequent in the apoplexy group than in the non-apoplexy group (P = .09 and.08, respectively). Furthermore, tumor diameter was not associated with pituitary apoplexy, whereas thyroid-stimulating hormone, luteinizing hormone, and follicle-stimulating hormone deficiencies were significantly associated with the apoplexy group (each P < .05). Hence, the present study indicated that pituitary apoplexy could not be related to tumor diameter. Moreover, hormonal deficiencies, hepatic dysfunction, hyponatremia or hypochloremia, and dyslipidemia might be indicators of pituitary apoplexy. There could be the possibility the treatment for dyslipidemia prevents pituitary apoplexy. Lippincott Williams & Wilkins 2022-12-16 /pmc/articles/PMC9771219/ /pubmed/36550872 http://dx.doi.org/10.1097/MD.0000000000032026 Text en Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC) (https://creativecommons.org/licenses/by-nc/4.0/) , where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. |
spellingShingle | 4300 Takeshita, Kaori Abe, Ichiro Kameda, Wataru Ishii, Kota Fujita, Yuya Nagata, Mai Ochi, Kentaro Senda, Yuki Koga, Midori Kudo, Tadachika Hada, Yurika Takase, Kaoru Morinaga, Yusuke Ito, Miiko Abe, Makiko Ishizawa, Kenichi Kobayashi, Kunihisa Clinical evaluations of pituitary apoplexy in incidental nonfunctional pituitary adenomas |
title | Clinical evaluations of pituitary apoplexy in incidental nonfunctional pituitary adenomas |
title_full | Clinical evaluations of pituitary apoplexy in incidental nonfunctional pituitary adenomas |
title_fullStr | Clinical evaluations of pituitary apoplexy in incidental nonfunctional pituitary adenomas |
title_full_unstemmed | Clinical evaluations of pituitary apoplexy in incidental nonfunctional pituitary adenomas |
title_short | Clinical evaluations of pituitary apoplexy in incidental nonfunctional pituitary adenomas |
title_sort | clinical evaluations of pituitary apoplexy in incidental nonfunctional pituitary adenomas |
topic | 4300 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9771219/ https://www.ncbi.nlm.nih.gov/pubmed/36550872 http://dx.doi.org/10.1097/MD.0000000000032026 |
work_keys_str_mv | AT takeshitakaori clinicalevaluationsofpituitaryapoplexyinincidentalnonfunctionalpituitaryadenomas AT abeichiro clinicalevaluationsofpituitaryapoplexyinincidentalnonfunctionalpituitaryadenomas AT kamedawataru clinicalevaluationsofpituitaryapoplexyinincidentalnonfunctionalpituitaryadenomas AT ishiikota clinicalevaluationsofpituitaryapoplexyinincidentalnonfunctionalpituitaryadenomas AT fujitayuya clinicalevaluationsofpituitaryapoplexyinincidentalnonfunctionalpituitaryadenomas AT nagatamai clinicalevaluationsofpituitaryapoplexyinincidentalnonfunctionalpituitaryadenomas AT ochikentaro clinicalevaluationsofpituitaryapoplexyinincidentalnonfunctionalpituitaryadenomas AT sendayuki clinicalevaluationsofpituitaryapoplexyinincidentalnonfunctionalpituitaryadenomas AT kogamidori clinicalevaluationsofpituitaryapoplexyinincidentalnonfunctionalpituitaryadenomas AT kudotadachika clinicalevaluationsofpituitaryapoplexyinincidentalnonfunctionalpituitaryadenomas AT hadayurika clinicalevaluationsofpituitaryapoplexyinincidentalnonfunctionalpituitaryadenomas AT takasekaoru clinicalevaluationsofpituitaryapoplexyinincidentalnonfunctionalpituitaryadenomas AT morinagayusuke clinicalevaluationsofpituitaryapoplexyinincidentalnonfunctionalpituitaryadenomas AT itomiiko clinicalevaluationsofpituitaryapoplexyinincidentalnonfunctionalpituitaryadenomas AT abemakiko clinicalevaluationsofpituitaryapoplexyinincidentalnonfunctionalpituitaryadenomas AT ishizawakenichi clinicalevaluationsofpituitaryapoplexyinincidentalnonfunctionalpituitaryadenomas AT kobayashikunihisa clinicalevaluationsofpituitaryapoplexyinincidentalnonfunctionalpituitaryadenomas |